Document Detail


Percutaneous Nephrostomy Versus Indwelling Ureteral Stent in the Management of Gynecological Malignancies.
MedLine Citation:
PMID:  22315095     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
OBJECTIVES: The aims of this study were to evaluate the efficacy of retrograde ureteral stenting and to identify the predictive factors for potential failure of this technique in women with advanced gynecologic malignancies. METHODS: From 2006 to 2010, a retrospective analysis was performed on a total of 75 patients with ureteral obstruction due to gynecologic malignancies. This population was divided into group 1 (n = 50) in which retrograde stent placement was successful, and group 2 (n = 25) in which stent placement failed and subsequent percutaneous nephrostomy tube placement was required. Multivariate analysis was done to identify predictors of the failure of ureteral stent insertion. RESULTS: Multivariate analysis revealed that mean preprocedureal serum cystanin C greater than 2.5 mg/L and length of the ureteral obstruction greater than 3 cm were significant predictors of stent failure. Neither the causes nor location of obstruction predicted the need for percutaneous nephrostomy (PCN). No statistical significance was detected among the subgroups of patients with different degrees of hydronephrosis. Statistical significant differences were found between the 2 groups in procedural time, average cost, and mean interval of stent/catheter replacement. However, no statistically significant difference was found in the median survival time and overall stent-related or catheter-related complications between the 2 groups. CONCLUSIONS: Retrograde ureteral stenting is a first-line option for managing ureteral obstruction caused by gynecologic malignancies. However, in cases where the preprocedureal mean serum cystanin C is greater than 2.5 mg/L and the length of the ureteral obstruction segment is greater than 3 cm, these patients may be better served by percutaneous drainage.
Authors:
Yan Song; Xiang Fei; Yongsheng Song
Related Documents :
18824855 - Interferon-beta1b in multiple sclerosis: effect on progression of disability and clinic...
1224185 - Pilot-study on large-dose alternate-day steroid therapy in multiple sclerosis.
22571275 - Intermediate outcomes after transcorporal placement of an artificial urinary sphincter.
22720275 - Prediction and prevention of upper gastrointestinal bleeding after cardiac surgery: a c...
10461115 - Stenturia: an unusual manifestation of spontaneous ureteral stent fragmentation.
6703515 - Revascularization of the profunda femoris artery for limb salvage.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-2-4
Journal Detail:
Title:  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society     Volume:  -     ISSN:  1525-1438     ISO Abbreviation:  -     Publication Date:  2012 Feb 
Date Detail:
Created Date:  2012-2-8     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9111626     Medline TA:  Int J Gynecol Cancer     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Urology Division, Sheng Jing Hospital, China Medical University, Shenyang, PR China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Microparticles From Ovarian Carcinomas Are Shed Into Ascites and Promote Cell Migration.
Next Document:  The role of polymorphisms at position 89 in the HIV-1 protease gene in the development of drug resis...